Granted Patent
B2
US 8,389,556 · App. 13/068,708 · Granted Mar 5, 2013
Thiazolidinedione analogues
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to methods of using thiazolidinedione analogues of formula I: for treating Alzheimer's disease The terms R 1 , R 2 and R 3 are herein defined.
Claims (2)
1. A method of treating Alzheimer's disease comprising administering to a patient a pharmaceutical composition comprising Compound No. 1:
or a pharmaceutically acceptable salt thereof.
Assignments (4)
RELEASE OF SECURITY INTEREST
Recorded May 19, 2016
From: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 038652/0097 →
SECURITY INTEREST
Recorded May 3, 2016
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: ALZHEIMER DRUG DISCOVERY FOUNDATION
Reel/Frame 038447/0317 →
SECURITY AGREEMENT
Recorded Feb 5, 2014
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: SQUARE 1 BANK
Reel/Frame 032162/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 19, 2011
From: COLCA, GERARD R.; KLETZIEN, ROLF F.
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY
Reel/Frame 026928/0297 →
Continuity (4)
Continuation In Part
PCTUS2007006321
· Mar 14, 2007
Provisional Application
60782894
· Mar 16, 2006